Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

ALK-Positive Lung Cancer Clinical Trials Near Me

As of November 20, 2026, 23 ALK-Positive Lung Cancer clinical trials are recruiting now and 21 are not yet recruiting. In the US, 9 of them have at least 1 open site, across 18 states and Washington, DC. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:ALK-Positive Lung Cancer pageCompare treatmentsMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+26 more

All 23 ALK-Positive Lung Cancer trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
    Most sites in Florida, New York and California
    RecruitingPhase 3Ages 18+Nuvalent
    22US sites
    14 states
  2. A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
    Most sites in Massachusetts, Ohio and California
    RecruitingPhase 1/2Ages 18+TRIANA Biomedicines
    14US sites
    12 states
  3. A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
    Most sites in California, Colorado and Georgia
    RecruitingPhase 1Ages 18+Astellas Pharma Global Development
    9US sites
    8 states
  4. Gilteritinib for the Treatment of ALK NSCLC
    Most sites in California, District of Columbia and Michigan
    RecruitingPhase 1Ages 18+University of Michigan Rogel Cancer Center
    3US sites
    3 states
  5. AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
    Only in Texas
    RecruitingPhase 1Ages 18+Chugai Pharmaceutical
    1US site
  6. Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
    Only in Texas
    RecruitingPhase 2Ages 18+M.D. Anderson Cancer Center
    1US site
  7. Patient-centered, Optimal Integration of Survivorship and Palliative Care
    Only in Massachusetts
    RecruitingAges 18+Massachusetts General Hospital
    1US site
  8. Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
    Only in Virginia
    RecruitingPhase 1Nuvectis Pharma
    1US site
  9. A Real World Study of Ensartinib in Advanced ALK-positive NSCLC
    RecruitingAges 18+Peking Union Medical College Hospital
    No US site yet
  10. A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib
    RecruitingPhase 2Ages 18+Centro di Riferimento Oncologico - Aviano
    No US site yet
  11. Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
    RecruitingPhase 2Ages 18-75Hebei Medical University Fourth Hospital
    No US site yet
  12. Alectinib Pharmacokinetic in Patients With NSCLC
    RecruitingPhase 1/2Ages 18+Instituto Nacional de Cancerologia de Mexico
    No US site yet
  13. Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
    RecruitingAges 18+Groupe Francais De Pneumo-Cancerologie
    No US site yet
  14. Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
    RecruitingAges 18+Pfizer
    No US site yet
  15. Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study
    RecruitingAges 18+Guangdong Association of Clinical Trials
    No US site yet
  16. Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
    RecruitingAges 18+Peking University Shenzhen Hospital
    No US site yet
  17. Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC
    RecruitingPhase 2Ages 18+Guangdong Association of Clinical Trials
    No US site yet
  18. Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
    RecruitingPhase 1/2Ages 18-75Tang-Du Hospital
    No US site yet
  19. Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer
    RecruitingPhase 2Ages 18+Pingping Song
    No US site yet
  20. Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
    RecruitingPhase 3Ages 18-99Tata Memorial Hospital
    No US site yet
Get an email when ALK-Positive Lung Cancer trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for ALK-Positive Lung Cancer:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the ALK-Positive Lung Cancer trials in the US, and what stage they are in

Of the 9 ALK-Positive Lung Cancer trials with a US site, 1 is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 7 of them. The last one has no drug phase, such as a study that follows people over time or tests a device or a way of giving care. Companies run 5 of them, and universities, hospitals, foundations and government groups run 4. The most recently listed one first appeared on ClinicalTrials.gov on November 16, 2026.

ALK-Positive Lung Cancer trials in the US, state by state

Of the 9 ALK-Positive Lung Cancer trials with a US site, 1 accepts children under 18. Its open sites are in Virginia. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
California404Orange (2), Fullerton (1), Los Angeles (1), plus 2 more
Massachusetts404Boston (4)
Texas404Houston (3), Dallas (1)
Virginia414Fairfax (4)
Colorado303Aurora (1), Boulder (1), Edwards (1)
Missouri303St Louis (3)
Georgia202Atlanta (2)
Michigan202Ann Arbor (2)
New York202New York (2), Westbury (1)
North Carolina202Durham (2), Charlotte (1)
Show the other 9 states
Ohio202Cincinnati (2), Columbus (1), Maumee (1)
Pennsylvania202Pittsburgh (1), Sellersville (1)
Tennessee202Nashville (2)
Arizona101Glendale (1)
District of Columbia101Washington D.C. (1)
Florida101Miami (1), Orlando (1), Tampa (1)
Illinois101Peoria (1)
Utah101West Valley City (1)
Washington101Seattle (1), Vancouver (1)

US hospitals running the most ALK-Positive Lung Cancer trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know ALK-Positive Lung Cancer.

  1. Massachusetts General HospitalBoston, Massachusetts2 trials
  2. NEXT VirginiaFairfax, Virginia2 trials
  3. SCRI Oncology PartnersNashville, Tennessee2 trials
  4. University of Cincinnati Cancer CenterCincinnati, Ohio2 trials
  5. AdventHealth Cancer InstituteOrlando, Florida1 trial
  6. Alliance Cancer SpecialistsSellersville, Pennsylvania1 trial
  7. Brigham and Women's HospitalBoston, Massachusetts1 trial
  8. Carolinas Medical CenterCharlotte, North Carolina1 trial
  9. Cedars-Sinai Medical CenterLos Angeles, California1 trial
  10. Compass OncologyVancouver, Washington1 trial

Help getting to an ALK-Positive Lung Cancer trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Corporate Angel Network
Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
American Cancer Society Hope Lodge
Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
Ronald McDonald House
Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding an ALK-Positive Lung Cancer trial near you

Are there ALK-Positive Lung Cancer clinical trials near me?

As of November 20, 2026, 23 ALK-Positive Lung Cancer clinical trials are recruiting now and 21 are not yet recruiting. In the US, 9 of them have at least 1 open site, across 18 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have ALK-Positive Lung Cancer clinical trial sites?

Recruiting ALK-Positive Lung Cancer trials list open sites in 18 states and Washington, DC. California, Massachusetts and Texas have the most, and the table on this page lists every state.

Are there ALK-Positive Lung Cancer trials for children near me?

Of the 9 ALK-Positive Lung Cancer trials with a US site, 1 accepts children under 18. Its open sites are in Virginia. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to an ALK-Positive Lung Cancer clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.

What if there is no ALK-Positive Lung Cancer trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when an ALK-Positive Lung Cancer trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

FDA-approved for ALK-Positive Lung Cancer: Nelkarmi (neladalkib), Lorbrena (lorlatinib), Alecensa (alectinib), Alunbrig (brigatinib), Ensacove (ensartinib), Xalkori (crizotinib), Zykadia (ceritinib).

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 20, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.